BRPI0710656A2 - ácidos bifenil carboxìlicos substituìdos e derivados dos mesmos - Google Patents

ácidos bifenil carboxìlicos substituìdos e derivados dos mesmos Download PDF

Info

Publication number
BRPI0710656A2
BRPI0710656A2 BRPI0710656-4A BRPI0710656A BRPI0710656A2 BR PI0710656 A2 BRPI0710656 A2 BR PI0710656A2 BR PI0710656 A BRPI0710656 A BR PI0710656A BR PI0710656 A2 BRPI0710656 A2 BR PI0710656A2
Authority
BR
Brazil
Prior art keywords
formula
trifluoromethyl
compound
biphenyl
original document
Prior art date
Application number
BRPI0710656-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Francis Wilson
Alison Jones
Valerie Reader
Richard John Harrison
Mihiro Sunose
Remedios Hernadez-Perni
Jeremy Major
Cyrille Boussard
Kathryn Bell
Jess Taylor
Adeline Morel
Andrew Cansfield
Svenja Burckhardt
Chih Yung Ho
Yan Zhang
Original Assignee
Cellzome Ltd
Ortho Mcneil Janssen Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellzome Ltd, Ortho Mcneil Janssen Pharm filed Critical Cellzome Ltd
Publication of BRPI0710656A2 publication Critical patent/BRPI0710656A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BRPI0710656-4A 2006-04-21 2007-04-20 ácidos bifenil carboxìlicos substituìdos e derivados dos mesmos BRPI0710656A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06112938.3 2006-04-21
EP06112938A EP1849762B1 (en) 2006-04-21 2006-04-21 Substituted biphenyl carboxylic acids and derivatives thereof
PCT/US2007/067039 WO2007124394A1 (en) 2006-04-21 2007-04-20 Substituted biphenyl carboxylic acids and derivatives thereof

Publications (1)

Publication Number Publication Date
BRPI0710656A2 true BRPI0710656A2 (pt) 2011-08-16

Family

ID=36688012

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0710656-4A BRPI0710656A2 (pt) 2006-04-21 2007-04-20 ácidos bifenil carboxìlicos substituìdos e derivados dos mesmos

Country Status (35)

Country Link
US (1) US7557244B2 (xx)
EP (2) EP1849762B1 (xx)
JP (1) JP5479088B2 (xx)
KR (1) KR101542255B1 (xx)
CN (1) CN101687758B (xx)
AP (1) AP2008004656A0 (xx)
AR (1) AR060568A1 (xx)
AU (1) AU2007240335B2 (xx)
BR (1) BRPI0710656A2 (xx)
CA (1) CA2650006C (xx)
CR (2) CR10375A (xx)
CY (1) CY1109399T1 (xx)
DE (1) DE602006007810D1 (xx)
DK (1) DK1849762T3 (xx)
EA (1) EA016129B9 (xx)
ES (2) ES2328616T3 (xx)
GE (1) GEP20115269B (xx)
GT (1) GT200900120A (xx)
IL (2) IL194790A (xx)
MA (1) MA30475B1 (xx)
MX (1) MX2008013445A (xx)
MY (1) MY148953A (xx)
NO (1) NO20084517L (xx)
NZ (1) NZ573000A (xx)
PE (1) PE20080364A1 (xx)
PL (1) PL1849762T3 (xx)
PT (1) PT1849762E (xx)
SI (1) SI1849762T1 (xx)
SM (1) SMP200800061B (xx)
TN (1) TNSN08413A1 (xx)
TW (1) TWI399362B (xx)
UA (1) UA95952C2 (xx)
UY (1) UY30301A1 (xx)
WO (1) WO2007124394A1 (xx)
ZA (1) ZA200809856B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5543354B2 (ja) * 2007-10-19 2014-07-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ γ−セクレターゼのアミン結合調節物質
EP2215043B1 (en) 2007-10-19 2013-03-06 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
EA017119B1 (ru) 2007-10-19 2012-09-28 Янссен Фармацевтика, Н.В. МОДУЛЯТОРЫ АКТИВНОСТИ γ-СЕКРЕТАЗЫ ИЗ ГРУППЫ ПИПЕРИДИНИЛА И ПИПЕРАЗИНИЛА
JP2011500720A (ja) * 2007-10-19 2011-01-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｇｓｍ中間体
WO2009067493A2 (en) * 2007-11-19 2009-05-28 Envivo Pharmaceuticals, Inc. 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
RU2527177C2 (ru) 2007-12-20 2014-08-27 Энвиво Фармасьютикалз, Инк. Четырехзамещенные бензолы
WO2011046774A1 (en) * 2009-10-16 2011-04-21 Merck Sharp & Dohme Corp. Diaryl ether derivatives as notch sparing gamma secretase inhibitors
US8785481B2 (en) 2010-09-29 2014-07-22 Merck Sharp & Dohme Corp. Ether benzotriazole derivatives
CA2828764A1 (en) * 2011-03-03 2012-09-07 Treventis Corporation Anti-amyloid compounds and methods
WO2015109109A1 (en) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Fused morpholinopyrimidines and methods of use thereof
WO2016201168A1 (en) 2015-06-10 2016-12-15 Forum Pharmceuticals Inc. Oxadiazine compounds and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877399A (en) * 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
JP3802581B2 (ja) * 1995-03-01 2006-07-26 富山化学工業株式会社 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
DE10131899A1 (de) 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
JP3852708B2 (ja) * 2002-06-27 2006-12-06 アステラス製薬株式会社 アミノアルコール誘導体
GB0305918D0 (en) * 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
WO2005110963A1 (en) * 2004-05-19 2005-11-24 Cellzome Ag (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy
GB0416508D0 (en) * 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
WO2006022237A1 (ja) * 2004-08-24 2006-03-02 Kissei Pharmaceutical Co., Ltd. 脂肪肝の予防または治療剤
EP1937632A1 (en) * 2005-10-06 2008-07-02 Astra Zeneca AB Novel compounds

Also Published As

Publication number Publication date
IL194852A0 (en) 2009-08-03
MA30475B1 (fr) 2009-06-01
NO20084517L (no) 2009-01-13
US7557244B2 (en) 2009-07-07
UY30301A1 (es) 2007-08-31
SMP200800061B (it) 2009-07-14
ES2328616T3 (es) 2009-11-16
AR060568A1 (es) 2008-06-25
JP2009544573A (ja) 2009-12-17
TNSN08413A1 (en) 2010-04-14
TWI399362B (zh) 2013-06-21
EP1849762A1 (en) 2007-10-31
EP1849762B1 (en) 2009-07-15
AU2007240335B2 (en) 2013-05-02
DK1849762T3 (da) 2009-10-12
CY1109399T1 (el) 2014-07-02
CR10451A (es) 2009-03-31
WO2007124394A1 (en) 2007-11-01
SI1849762T1 (sl) 2009-12-31
CA2650006C (en) 2016-08-23
UA95952C2 (ru) 2011-09-26
KR20090024679A (ko) 2009-03-09
CA2650006A1 (en) 2007-11-01
NZ573000A (en) 2011-11-25
EA016129B9 (ru) 2012-06-29
EP2021314A1 (en) 2009-02-11
IL194790A (en) 2012-12-31
SMAP200800061A (it) 2008-11-19
TW200815320A (en) 2008-04-01
ES2400530T3 (es) 2013-04-10
AP2008004656A0 (en) 2008-10-31
MY148953A (en) 2013-06-14
EP2021314B1 (en) 2013-01-23
KR101542255B1 (ko) 2015-08-06
CN101687758A (zh) 2010-03-31
PE20080364A1 (es) 2008-05-16
AU2007240335A1 (en) 2007-11-01
DE602006007810D1 (de) 2009-08-27
ZA200809856B (en) 2009-06-24
PL1849762T3 (pl) 2009-12-31
GEP20115269B (en) 2011-08-25
MX2008013445A (es) 2009-03-10
EA016129B1 (ru) 2012-02-28
CN101687758B (zh) 2014-05-14
JP5479088B2 (ja) 2014-04-23
US20070293567A1 (en) 2007-12-20
PT1849762E (pt) 2009-09-16
IL194790A0 (en) 2009-08-03
GT200900120A (es) 2009-11-16
CR10375A (es) 2009-02-26
EA200802172A1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
BRPI0710656A2 (pt) ácidos bifenil carboxìlicos substituìdos e derivados dos mesmos
ES2392352T3 (es) Derivados de terfenilo para el tratamiento de la enfermedad de Alzheimer
JP5054532B2 (ja) （ビフェニル）カルボン酸およびその誘導体
EP2215044B1 (en) Biphenyl carboxylic acids and derivatives thereof

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: ESCLARECA A DIVERGENCIA NO NOME DOS INVENTORES REID, ALISON E SMELT, KATHRYN CONSTANTE TANTO NA PUBLICACAO INTERNACIONAL COMO NA FOLHA DE ROSTO DO DOCUMENTO DE PRIORIDADE, COM O NOME PREENCHIDO NA PETICAO JONES, ALISON E BELL, KATHRYN

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2256 DE 01/04/2014.